- List
- By Topic
- On Map
- Search Details

Recruiting, Not yet recruiting, Available Studies | "Hypoglycemic Agents"
Need help? See RSS Feeds
Choose a feed type:

Recruiting, Not yet recruiting, Available Studies | "Hypoglycemic Agents" (34 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02671864 | Recruiting | Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy |
|
|
Interventional | Not Applicable |
|
Other |
|
|
7200 | All | 18 Years and older (Adult, Senior) | NCT02671864 | P150601 | ANGIOSAFE 2 | April 11, 2016 | April 11, 2022 | April 11, 2022 | February 2, 2016 | August 29, 2017 |
|
|
2 | NCT02885922 | Recruiting | The Effects of add-on Anti-diabetic Drugs in Type 2 Diabetic Patients |
|
|
Observational |
|
Other |
|
|
6000 | All | 20 Years and older (Adult, Senior) | NCT02885922 | CG16183A | September 2016 | December 2020 | December 2020 | September 1, 2016 | March 27, 2018 |
|
|||
3 | NCT02925559 | Not yet recruiting | Effect of Anti-diabetic Drugs on Glycemic Variability |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
120 | All | 40 Years and older (Adult, Senior) | NCT02925559 | ESR-14-10377 | EFFORT | October 2016 | December 2017 | December 2017 | October 6, 2016 | October 6, 2016 |
|
|
4 | NCT02695121 | Recruiting | Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment |
|
Observational |
|
Industry |
|
|
99999 | All | Child, Adult, Senior | NCT02695121 | D1690R00007 EUPAS12116 |
February 29, 2016 | April 30, 2024 | April 30, 2024 | March 1, 2016 | April 10, 2018 |
|
||||
5 | NCT02695082 | Recruiting | Acute Kidney Injury in Patients on Dapagliflozin and Other Antidiabetic Medications |
|
Observational |
|
Industry |
|
|
91927 | All | Child, Adult, Senior | NCT02695082 | D1690R00004 EUPAS11684 |
February 29, 2016 | November 30, 2019 | November 30, 2019 | March 1, 2016 | April 10, 2018 |
|
||||
6 | NCT02336217 | Recruiting | Glycemic Emergency Management (GEM); An App for Rapid Response to Hypoglycemic and Hyperglycemic Situations |
|
|
Interventional | Not Applicable |
|
Other |
|
|
60 | All | 18 Years to 70 Years (Adult, Senior) | NCT02336217 | 574049 | GEMApp | September 2014 | September 2019 | September 2019 | January 12, 2015 | June 7, 2017 |
|
|
7 | NCT03485222 | Not yet recruiting New |
Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4). |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
80 | All | 18 Years and older (Adult, Senior) | NCT03485222 | GCO 17-2457 | EMPA-TROPISM | May 2018 | December 2020 | December 2020 | April 2, 2018 | April 2, 2018 |
|
|
8 | NCT03010956 | Recruiting | Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication. |
|
Observational |
|
Other |
|
|
60 | All | 18 Years to 70 Years (Adult, Senior) | NCT03010956 | S-DM-ATTIKON | November 2014 | June 2017 | November 2017 | January 5, 2017 | January 5, 2017 |
|
||||
9 | NCT03172494 | Recruiting | A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs) |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
720 | All | 18 Years and older (Adult, Senior) | NCT03172494 | NN9068-4148 U1111-1154-6671 CTR20170004 |
DUAL™ I China | May 26, 2017 | December 10, 2018 | July 29, 2019 | June 1, 2017 | March 26, 2018 |
|
|
10 | NCT03434119 | Recruiting | Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
1200 | All | 18 Years and older (Adult, Senior) | NCT03434119 | LPS14860 U1111-1200-1891 |
LixiLan-D | February 20, 2018 | September 2019 | September 2019 | February 15, 2018 | March 2, 2018 |
|
|
11 | NCT03492580 | Recruiting New |
A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease |
|
|
Observational |
|
Industry |
|
|
714582 | All | Child, Adult, Senior | NCT03492580 | CR108464 RRA-20250 |
February 22, 2018 | June 30, 2018 | June 30, 2018 | April 10, 2018 | April 10, 2018 |
|
|||
12 | NCT03414736 | Recruiting | A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
60 | All | 18 Years to 75 Years (Adult, Senior) | NCT03414736 | TDR15516 U1111-1205-1368 |
January 19, 2018 | October 2018 | October 2018 | January 30, 2018 | April 12, 2018 |
|
||
13 | NCT02855684 | Recruiting | Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
600 | All | 18 Years and older (Adult, Senior) | NCT02855684 | EFC12814 U1111-1139-3894 |
EDITION AP | August 24, 2016 | August 6, 2018 | August 6, 2018 | August 4, 2016 | April 12, 2018 |
|
|
14 | NCT02752412 | Recruiting | Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Drugs |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
534 | All | 20 Years and older (Adult, Senior) | NCT02752412 | EFC14113 U1111-1176-8378 |
LIXILAN JP-L | May 17, 2016 | October 3, 2018 | October 3, 2018 | April 27, 2016 | April 12, 2018 |
|
|
15 | NCT00658021 | Recruiting | Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
195 | All | 10 Years to 17 Years (Child) | NCT00658021 | D5550C00002 | May 30, 2008 | March 10, 2020 | March 6, 2023 | April 14, 2008 | April 10, 2018 |
|
||
16 | NCT03269058 | Not yet recruiting | Evaluate the Effects of Dapagliflozin in Patients With Type 2 Diabetes |
|
|
Interventional | Phase 4 |
|
Other |
|
|
28 | All | 30 Years to 65 Years (Adult) | NCT03269058 | VERGES AZ 2015 | Cinétique DAPA | September 2017 | March 2019 | March 2019 | August 31, 2017 | August 31, 2017 |
|
|
17 | NCT01897688 | Recruiting | A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients |
|
|
Interventional | Phase 3 |
|
Other |
|
|
20 | All | 18 Years to 65 Years (Adult) | NCT01897688 | STU00059469 | June 2012 | March 2020 | March 2021 | July 12, 2013 | April 20, 2018 |
|
||
18 | NCT03448965 | Not yet recruiting | Hypoglycemic and Hyperglycemic Disorders |
|
|
Observational |
|
Other |
|
|
100 | All | up to 28 Days (Child) | NCT03448965 | NGD | December 15, 2018 | October 20, 2019 | December 31, 2019 | February 28, 2018 | February 28, 2018 | ||||
19 | NCT02231021 | Recruiting | The Practical Evidence of Antidiabetic Combination Therapy in Korea |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
300 | All | 19 Years to 75 Years (Adult, Senior) | NCT02231021 | ALO-IIT-012 | PEAK | September 2014 | June 2018 | November 2018 | September 3, 2014 | July 14, 2017 |
|
|
20 | NCT02926937 | Recruiting | Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
400 | All | 18 Years and older (Adult, Senior) | NCT02926937 | EFC14833 2016‐001799‐31 U1111-1180-6169 |
November 11, 2016 | January 14, 2019 | January 14, 2019 | October 6, 2016 | April 12, 2018 |
|
||
21 | NCT03285594 | Recruiting | Efficacy and Safety of Sotagliflozin Versus Placebo in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking Insulin Alone or With Other Oral Antidiabetic Agents |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
560 | All | 18 Years and older (Adult, Senior) | NCT03285594 | EFC14868 2016‐001804‐43 U1111-1190-7567 |
SOTA-INS | September 15, 2017 | May 2019 | May 2019 | September 18, 2017 | April 23, 2018 |
|
|
22 | NCT03175120 | Recruiting | A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD) |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
450 | All | 18 Years and older (Adult, Senior) | NCT03175120 | NN9068-4166 U1111-1154-6732 CTR20060909 |
DUAL™ II China | May 26, 2017 | December 10, 2018 | January 14, 2019 | June 5, 2017 | April 17, 2018 |
|
|
23 | NCT03241706 | Not yet recruiting | Liver Glycogen and Hypoglycemia in Humans |
|
|
Interventional | Phase 1 |
|
Other |
|
|
40 | All | 21 Years to 40 Years (Adult) | NCT03241706 | 2016-7982 | September 1, 2017 | May 31, 2021 | May 31, 2022 | August 7, 2017 | August 7, 2017 | |||
24 | NCT03423381 | Recruiting | Dietary Fibre and Metabolic Benefits |
|
|
Interventional | Not Applicable |
|
Other |
|
|
20 | All | 20 Years to 70 Years (Adult, Senior) | NCT03423381 | 2017-03575 | April 10, 2018 | October 30, 2019 | October 30, 2019 | February 6, 2018 | March 26, 2018 |
|
||
25 | NCT03006510 | Not yet recruiting | Hypoglycemia Prediction Model |
|
|
Interventional | Early Phase 1 |
|
Other |
|
|
6500 | All | 18 Years and older (Adult, Senior) | NCT03006510 | 16-20565 | January 2017 | January 2018 | July 2018 | December 30, 2016 | December 30, 2016 | |||
26 | NCT02695095 | Recruiting | Acute Liver Injury in Patients on Dapagliflozin |
|
Observational |
|
Industry |
|
|
91927 | All | Child, Adult, Senior | NCT02695095 | D1690R00005 | February 29, 2016 | November 30, 2019 | November 30, 2019 | March 1, 2016 | April 10, 2018 |
|
||||
27 | NCT02695173 | Recruiting | Complications of UTI in Patients on Dapagliflozin |
|
Observational |
|
Industry |
|
|
91927 | All | Child, Adult, Senior | NCT02695173 | D1690R00008 EUPAS12113 |
February 29, 2016 | November 30, 2019 | November 30, 2019 | March 1, 2016 | April 10, 2018 |
|
||||
28 | NCT02163044 | Recruiting | The Hellenic Postprandial Lipemia Study (HPLS) |
|
Observational |
|
Other |
|
|
1200 | All | 18 Years to 90 Years (Adult, Senior) | NCT02163044 | 2014-HPLS-IIS | HPLS | September 2014 | June 2018 | June 2018 | June 13, 2014 | March 7, 2018 |
|
|||
29 | NCT03460899 | Recruiting | Impact of Hypoglycaemia in Patients With DIAbetes Mellitus Type 2 on PLATElet Activation |
|
|
Interventional | Not Applicable |
|
Other / Industry |
|
|
14 | All | 18 Years to 64 Years (Adult) | NCT03460899 | HS-2017-04 | Diaplate | February 12, 2018 | April 11, 2018 | April 19, 2018 | March 9, 2018 | March 20, 2018 |
|
|
30 | NCT01733459 | Recruiting | Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS) |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
124 | Female | 18 Years to 40 Years (Adult) | NCT01733459 | DLBS3233-0811 | March 2013 | April 2018 | June 2018 | November 27, 2012 | November 27, 2017 |
|
||
31 | NCT02953665 | Recruiting | Safety and Efficacy of Liraglutide in Parkinson's Disease |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
57 | All | 25 Years to 85 Years (Adult, Senior) | NCT02953665 | U1111-1173-0106 | April 3, 2017 | July 2019 | September 2019 | November 3, 2016 | April 17, 2018 |
|
||
32 | NCT02844153 | Recruiting | Metformin Use in Chronic Kidney Disease: The CKD-Met Study |
|
|
Observational |
|
Other |
|
|
1000 | All | 18 Years and older (Adult, Senior) | NCT02844153 | 69HCL16_0408 | CKD-Met | March 2014 | March 2018 | March 2020 | July 26, 2016 | July 26, 2016 |
|
||
33 | NCT02864953 | Not yet recruiting | Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
680 | All | 18 Years to 85 Years (Adult, Senior) | NCT02864953 | 252LH301 RPI 301 2017-004854-41 |
CHARM | June 29, 2018 | September 28, 2020 | June 28, 2021 | August 12, 2016 | March 22, 2018 | ||
34 | NCT01258075 | Recruiting | Colesevelam Pediatric Type 2 Diabetes Mellitus Study |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
230 | All | 10 Years to 17 Years (Child) | NCT01258075 | WEL-A-U307 | WELKid DM | November 2010 | June 2019 | June 2019 | December 10, 2010 | December 27, 2017 |
|
† Study has passed its completion date and status has not been verified in more than two years.